Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Experts disagree with USPSTF’s take on pediatric blood pressure screening

Key clinical point: The U.S. Preventive Services Task Force’s search of the literature found insufficient studies to make its argument.

Major finding: The U.S. Preventive Services Task Force finds current evidence insufficient to assess the benefits and harms of pediatric BP screening.

Study details: A systematic evidence review updating the 2013 U.S. Preventive Services Task Force recommendation to include available evidence on secondary hypertension.

Disclosures: All members of the U.S. Preventive Services Task Force received travel reimbursement and honoraria. Dr. Barry received grants and personal fees from Healthwise. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.


USPSTF. JAMA. 2020 Nov 10. doi: 10.1001/jama.2020.20122.